Atlas Trials

Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

Clinical trial NCT03887013 · UNKNOWN

Trial details

NCT number
NCT03887013
Sponsor
China National Center for Cardiovascular Diseases
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Heart DiseaseDiastolic Dysfunction
Start date
2019-03-25
Primary completion
2020-10-01
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.